FDA allows four firms to make generic solution

Washington, DC-Four manufacturers of ocular products have received FDA approval to market ofloxacin ophthalmic solution 0.3%, a generic version of Allergan Inc.'s Ocuflox, for the treatment of certain strains of bacteria in conjunctivitis and corneal ulcers.

Related Videos
View All
Related Content
© 2023 MJH Life Sciences

All rights reserved.